Clark James David has filed 14 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 11138 shares of CVS HEALTH Corp ($CVS) on March 31, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock (Restricted) | 11138 | $71.82 | 35,539.0000 | 1,271,000,000 | 45.65% | 0.00% |
| March 31, 2026 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | A | Stock Option | 11976 | $71.82 | 11,976.0000 | 1,271,000,000 | 9999.99% | 0.00% |
| April 1, 2026 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 3262 | $72.49 | 15,457.0000 | 1,271,000,000 | 17.43% | 0.00% |
| Dec. 1, 2025 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock (Restricted) | 220 | $79.10 | 24,401.0000 | 1,269,000,000 | 0.89% | 0.00% |
| April 1, 2025 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 2266 | $67.98 | 11,240.0000 | 1,262,000,000 | 16.78% | 0.00% |
| April 1, 2025 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock (Restricted) | 14710 | $67.98 | 24,707.0000 | 1,262,000,000 | 147.14% | 0.00% |
| March 5, 2025 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | M | Stock Option | 7513 | $0.00 | 0.0000 | 1,262,000,000 | 100.00% | 0.00% |
| March 5, 2025 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | M | Common Stock | 7513 | $62.21 | 15,907.0000 | 1,262,000,000 | 89.50% | 0.00% |
| March 5, 2025 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | S | Common Stock | 7513 | $66.35 | 8,394.0000 | 1,262,000,000 | 47.23% | 0.00% |
| Nov. 30, 2024 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 86 | $59.85 | 8,394.0000 | 1,262,000,000 | 1.01% | 0.00% |
| April 1, 2024 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 1892 | $79.56 | 9,592.0000 | 1,290,000,000 | 16.48% | 0.00% |
| April 1, 2024 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock (Restricted) | 10683 | $79.56 | 15,109.0000 | 1,290,000,000 | 241.37% | 0.00% |
| April 1, 2024 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | F | Common Stock | 1112 | $79.56 | 8,480.0000 | 1,290,000,000 | 11.59% | 0.00% |
| Feb. 12, 2024 | CVS HEALTH Corp | $CVS | Clark James David | SVP, Cont & Chief Acct Officer | A | Common Stock | 2452 | $0.00 | 7,150.0000 | 1,290,000,000 | 52.19% | 0.00% |